Skip to content

Evaluation of Gabapentine 5% mouthwash on chemotherapy induced stomatitis

Evaluation of Gabapentine 5% mouthwash on chemotherapy induced stomatitis on cancer patients

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201612073014N17
Enrollment
60
Registered
2017-01-02
Start date
2016-11-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chemotherapy induced oral mucositis( stomatitis). Oral mucositis (ulcerative) due to antineoplastic therapy

Interventions

Intervention 1: Gabapentine mouthwash (5 percent) ,7.5 ml ,three times a day for 2 weeks. Intervention 2: Placebo mouthwash ,7.5 ml, 3 times a day for 2 weeks.
Treatment - Drugs
Placebo
Gabapentine mouthwash (5 percent) ,7.5 ml ,three times a day for 2 weeks
Placebo mouthwash ,7.5 ml, 3 times a day for 2 weeks

Sponsors

Vice chancellor for research, Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:cancer patients receiving chemotherapy regimens containing 5_fluorouracil , anthracyclines or high dose of methotrexate Exclusion criteria: Gabapentine intolerance , inappropriate use of the mouth wash or oral use of Gabapentine

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: After 1 week of intervention. Method of measurement: Quastionnaire.

Secondary

MeasureTime frame
Dysphagia to liquids. Timepoint: Before and after 2 weeks of intervention. Method of measurement: Ask a question.;Dysphagia to solids. Timepoint: Before and after 2 weeks of intervention. Method of measurement: Ask a question.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNeda Zamani

Vice chancellor for research, Mazandaran University of Medical Sciences

sh204ala@yahoo.com zamani_neda71@yahoo.comzamani.masoumeh1991@gmail.com+98 11 3336 9272

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026